These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets. Darius H; Veit K; Binz C; Fisch A; Meyer J Agents Actions Suppl; 1995; 45():77-83. PubMed ID: 7536385 [TBL] [Abstract][Full Text] [Related]
8. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells. Hall JM; Strange PG Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527 [TBL] [Abstract][Full Text] [Related]
9. Platelets Express Activated P2Y Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879 [TBL] [Abstract][Full Text] [Related]
10. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Schrör K; Löbel P; Steinhagen-Thiessen E Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819 [TBL] [Abstract][Full Text] [Related]
11. Expression of prostacyclin receptor in human megakaryocytes. Sasaki Y; Takahashi T; Tanaka I; Nakamura K; Okuno Y; Nakagawa O; Narumiya S; Nakao K Blood; 1997 Aug; 90(3):1039-46. PubMed ID: 9242534 [TBL] [Abstract][Full Text] [Related]
12. Interaction between platelet receptor and iloprost isomers. Tsai AL; Vijjeswarapu H; Wu KK Biochim Biophys Acta; 1988 Jul; 942(2):220-6. PubMed ID: 2456096 [TBL] [Abstract][Full Text] [Related]
13. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927 [TBL] [Abstract][Full Text] [Related]
14. Platelet prostacyclin binding in coronary artery disease. Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061 [TBL] [Abstract][Full Text] [Related]
15. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action. Seiler SM; Brassard CL; Federici ME; Buchanan JO; Zavoico GB; Fleming JS; Meanwell NA Thromb Res; 1994 Apr; 74(2):115-23. PubMed ID: 8029812 [TBL] [Abstract][Full Text] [Related]
16. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside. Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213 [TBL] [Abstract][Full Text] [Related]
17. Activation of the cloned platelet thrombin receptor decreases the pertussis-toxin-dependent ADP-ribosylation of the membrane and soluble inhibitory guanine-nucleotide-binding-alpha proteins. Inhibition by the prostacyclin analog, iloprost. Wilhelm B; Siess W Eur J Biochem; 1993 Aug; 216(1):81-8. PubMed ID: 7689967 [TBL] [Abstract][Full Text] [Related]
18. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation. Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792 [TBL] [Abstract][Full Text] [Related]
19. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Seiler SM; Brassard CL; Federici ME; Romine J; Meanwell NA Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. Darius H; Michael-Hepp J; Thierauch KH; Fisch A Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]